Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Epilepsy, Temporal Lobe: early-phase trial registry
4 of 5 indexed Epilepsy, Temporal Lobe trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Epilepsy, Temporal Lobe: 5 US clinical trials tracked, 4 recruiting.
Epilepsy, Temporal Lobe is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Neurological Disorders and Stroke (NINDS), running 3 of these trials.
Enrollment posture brief
Registry condition epilepsy-temporal-lobe
OPEN 4 | RECR 80% | LATE 0 | EARLY 2 | RANK #3391 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)
Epilepsy, Temporal Lobe lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Epilepsy, Temporal Lobe on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Epilepsy, Temporal Lobe is recruiting above its size-band peers.
4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Epilepsy, Temporal Lobe research.
National Institute of Neurological Disorders and Stroke (NINDS) accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.
-
Typical Epilepsy, Temporal Lobe enrolment sits around 290 participants.
Median target enrolment is 290 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Epilepsy, Temporal Lobe research leans observational.
2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Investigating Epilepsy: Screening and Evaluation
National Institute of Neurological Disorders and Stroke (NINDS)
NCT03478852
Surgery as a Treatment for Medically Intractable Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)
NCT01273129
Localizing Epileptic Networks Using MRI and iEEG
University of Pennsylvania
NCT04649008
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Neurona Therapeutics
NCT06422923
Light Scattering Spectroscopy to Determine Brain Tumors
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00067418
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Epilepsy, Temporal Lobe records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Epilepsy, Temporal Lobe trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Epilepsy, Temporal Lobe page
5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Epilepsy, Temporal Lobe trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Neurological Disorders and Stroke (NINDS) sponsors the most Epilepsy, Temporal Lobe trials on record, review their full trial history before evaluating a specific study. See National Institute of Neurological Disorders and Stroke (NINDS)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Epilepsy, Temporal Lobe condition card totals 5 registered trials; most-linked intervention 7T Magnetic Resonance Imaging; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.